Steven Boyd, Armistice

Steven Boyd, Armistice Capital Ranked #2 in Rising Hedge Fund Stars (Institutional Investor Magazine).

A handful were born outside the U.S., while others are first-generation Americans. Some were shoo-ins for the Ivy League, while several relied...

Internet Stock Review Initiates Coverage On HealthLynked Corp. (HLYK) $0.23.

NAPLES, Fla., Oct. 04, 2017 (GLOBE NEWSWIRE) -- HealthLynked Corp. (HLYK) today announced it has retained Institutional Analyst Inc., to provide coverage...
Biotech Stock Review, Dicerna DRNA

Adding Dicerna (DRNA) $3.30 to Watch List.

Adding Dicerna (DRNA) $3.30 to Watch List. How fun would it be to sell a $3.00 idea (IMMU) at...
Biotech Stock Review

Adding Immunomedics (IMMU) $3.00 to Watch List.

Biotech Stock Review Initiates Coverage. Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.

Largest Stem Cell Investor Conference Set to Be Held in New York City

Where Stem Cell Science, Meets Wall Street NEW YORK, NY--(Marketwired - Oct 6, 2015) - Investor Conference Network...
Roland Rick Perry, Biotech Stock Review

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.

“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
zestra, biotech stock review

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for...
Biotech Stock Review

Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association

WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry...

Latest article

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production...